Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Astellas Pharma Inc.    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news
Most relevant news about ASTELLAS PHARMA INC.
01/14ACTINIUM PHARMACEUTICALS : and Astellas Announce Research Collaboration Focused ..
AQ
01/06ASTELLAS PHARMA INC. : - FDA Accepts for Priority Review the New Drug Applicatio..
AQ
2020ASTELLAS PHARMA : FDA Lifts Clinical Hold for Audentes Therapeutics' AT132 Trial
MT
2020ASTELLAS PHARMA : Reports XOSPATA in Combination with Azacitidine Did Not Meet E..
AQ
2020ASTELLAS PHARMA : Supports Recommendations of Task Force on Climate-related Fina..
AQ
2020ASTELLAS PHARMA INC. : - Expansion of the Domestic Logistics Platform for Pharma..
AQ
2020VIATRIS : Astellas and Viatris Announce Termination of Co-promotion, Succession ..
AQ
2020Japan shares slip for third day; all eyes on U.S. stimulus debate
RE
2020Japanese shares slip back as investors look to U.S. stimulus debate
RE
2020Astellas Pharma, Viatris Pharmaceuticals Japan to End Joint Sales Promotion o..
MT
2020Astellas Receives Approval of EVRENZO in Japan for the Treatment of Anemia of..
AQ
2020Astellas Europe Transfers DIFICLIR Market Authorizations in EMEA, Select CIS ..
MT
2020Astellas Pharma Gets Approval for EVRENZO in Japan
MT
2020ASTELLAS PHARMA : Launches a 'Contact for Potential Acquisition of ' R&D Program..
AQ
2020Japan shares fall as virus surge, firmer yen weigh
RE
2020ASTELLAS PHARMA : to Present New Data on Gilteritinib in FLT3 Mutation-Positive ..
AQ
2020Astellas Pharma in Absorption-Type Merger with Two Subsidiaries
MT
2020ASTELLAS PHARMA INC. : - XTANDI Approved by China NMPA for the Treatment of Non-..
AQ
2020ASTELLAS PHARMA : Completes Acquisition of iota Biosciences
AQ
2020Astellas Pharma Acquires Iota Biosciences
MT
2020Japan stocks fall, post biggest weekly loss in 3 months on virus worries
RE
2020Japanese shares slump on virus worries, mixed earnings
RE
2020ASTELLAS PHARMA : Receives U.S. FDA Fast Track Designation for ASP5354, an Inves..
AQ
2020ASTELLAS PHARMA INC. : half-yearly earnings release
2020ASTELLAS PHARMA : ITI Announces Promotion of Dr. Tim Coleman to SVP, Operations ..
AQ
2020ASTELLAS PHARMA INC. : - U.S. FDA Grants Fast Track Designation for ASP0367/MA-0..
AQ
2020ASTELLAS PHARMA INC. : - New Roxadustat Data in Anemia of Chronic Kidney Disease..
AQ
2020ASTELLAS PHARMA : China Update – Drug Patents
AQ
2020ASTELLAS PHARMA : to acquire iota Biosciences
AQ
2020Nikkei flat as coronavirus resurgence in Europe hits sentiment
RE
2020ASTELLAS PHARMA : FibroGen to Present New Efficacy and Safety Analyses from Roxa..
AQ
2020ASTELLAS PHARMA : to Acquire iota Biosciences
BU
2020ASTELLAS PHARMA : and Seagen Announce Positive Topline Results from Second Cohor..
AQ
2020ASTELLAS PHARMA : and LabCentral Announce Golden Ticket Winners, Helping Emergin..
AQ
2020ASTELLAS PHARMA : Celebrates First-Ever Virtual Day of Service to Help Non-Profi..
AQ
2020ASTELLAS PHARMA : and MBC BioLabs Announce Golden Ticket Competition to Help Bio..
AQ
2020ASTELLAS PHARMA : Real-World Evidence Studies Provide Further Insight into Negat..
AQ
2020ASTELLAS PHARMA INC. : Ex-dividend day for interim dividend
FA
2020ASTELLAS PHARMA : and University of Pittsburgh Announce Research Collaboration f..
AQ
2020ASTELLAS PHARMA INC. : - Astellas Efforts against the Spread of the Coronavirus ..
AQ
2020ASTELLAS PHARMA : and Seattle Genetics Announce PADCEV Significantly Improved Ov..
AQ
2020ASTELLAS PHARMA : Collaborates with Two Research Centers at the University of To..
AQ
2020ASTELLAS PHARMA : and Seattle Genetics Announce PADCEV Significantly Improved Ov..
PU
2020Japan shares rise on hopes for U.S. economy, new prime minister eyed
RE
2020Japan stocks rise on U.S. data, easing concerns about new prime minister
RE
2020ASTELLAS PHARMA INC. : - Science-Based Fitness Service, Fit-eNce
AQ
2020Bayer takes on Astellas in purchase of experimental menopause relief
RE
2020ASTELLAS PHARMA : Open Innovation Challenge Astellas Rx+ Healthcare Innovation C..
AQ
2020ASTELLAS PHARMA INC. : quaterly earnings release
2020ASTELLAS PHARMA : is Awarded Grant from the U.S. National Institutes of Health t..
AQ
2020ASTELLAS PHARMA : Named to FTSE4Good Index Series for Ninth Consecutive Year
AQ
2020ASTELLAS PHARMA : Efforts against the Spread of the Coronavirus Disease
AQ
2020Japanese shares end almost flat just below three-month high as rally loses st..
RE
2020ASTELLAS PHARMA : Roxadustat Demonstrates Non-Inferiority to Darbepoetin in Phas..
AQ
2020ASTELLAS PHARMA : City of Yokohama, and Yokohama City University Developed Scien..
AQ
2020ASTELLAS PHARMA : Federal Circuit Reverses PTAB Finding Tarceva® Method Of Treat..
AQ
2020ASTELLAS PHARMA INC. : - FDA Approves VESIcare LS Oral Suspension for Pediatric ..
AQ
2020ASTELLAS PHARMA INC. : - Notice Regarding Continuation of the Performance-linked..
AQ
2020ASTELLAS PHARMA : European Medicines Agency Accepts Astellas Marketing Authoriza..
AQ
2020ASTELLAS PHARMA : Immunomic Therapeutics, Inc. - Maryland's Immunomic Therapeuti..
AQ
2020ASTELLAS PHARMA INC. : annual earnings release
2020ASTELLAS PHARMA : Efforts against the Spread of the Coronavirus Disease
AQ
2020ASTELLAS PHARMA : and Harvard Establish Strategic Research Alliance
PU
2020ASTELLAS PHARMA INC. : - Change of Directors and Organizational Change
AQ
2020ASTELLAS PHARMA : Announces Acquisition of Nanna
AQ
2020ASTELLAS PHARMA : Announces Acceptance of XOSPATA for Regulatory Review in China..
AQ
2020ASTELLAS PHARMA : and BANDAI NAMCO Entertainment Enter into Agreement to Co-Deve..
AQ
2020ASTELLAS PHARMA : Three Astellas Research and Production Facilities in Japan Ado..
PU
2020ASTELLAS PHARMA : Launches its Corporate Website's Science Section
PU
2020ASTELLAS PHARMA INC. : Ex-dividend day for final dividend
FA
2020CytomX Therapeutics and Astellas Announce Strategic Collaboration to Develop ..
AQ
2020ASTELLAS PHARMA : CytomX Therapeutics and Astellas Announce Strategic Collaborat..
PU
2020ASTELLAS PHARMA : Gifu University and Astellas establish a Research Course on Ph..
AQ
2020ASTELLAS PHARMA : Notice Regarding the Performance-linked Stock Compensation Sch..
PU
2020Seattle Genetics and Astellas Receive FDA Breakthrough Therapy Designation fo..
AQ
1  2  3  4  5  6  7  8Next
Upcoming event on ASTELLAS PHARMA INC.